(Reuters) -U.S. stock index futures edged lower on Tuesday after Wall Street's rally over the past few days following election results as traders awaited key inflation data later in the week for more ...

The Dow Jones Industrial Average declined 382.15 points ... Amgen stock price tanked 7%, Novavax shares plunged 6%, and ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

Major Wall Street indices closed lower on Tuesday as investors booked some profits from a post-election rally and turned ...

Novavax shares fell after the vaccine developer cut its full-year growth projections, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue. Write to Rob Curran at ...

Shares of Novavax Inc. NVAX slid 6.10% to $8.46 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to 19,281.40 ...

Investors are assessing whether the post-election rally is about to stall and what Donald Trump's Cabinet picks mean for ...

Wall Street's main indexes were little changed on Tuesday following post-election gains over the past few days.

Wall Street's main indexes fell on Tuesday as investors booked profits from post-election gains and awaited U.S. inflation ...

Investors are assessing whether the post-election rally is about to stall and what Donald Trump's Cabinet picks mean for ...

FY24 consensus $761.46M. Cuts FY24 product sales view to $175M-$225M from $275M-$375M. Raises FY24 Licensing, Royalties and Other Revenue view ...